Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar jsgant13 (97.73) Submitted: 2/8/2011 9:39:51 PM : Outperform Start Price: $3.50 OREX Score: -4.77

sac

Featured Broker Partners


Advertisement